Northwest Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Northwest Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$2K	–	430
2019 Q1	$2K	Hold	100	–	–	﹤0.01%	481
2018 Q4	$2K	Hold	100	–	–	﹤0.01%	469
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	486
2018 Q2	$2K	Hold	100	–	–	﹤0.01%	474
2018 Q1	$2K	Buy	+100	New	+$1.95K	﹤0.01%	488

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northwest Wealth Management's TEVA Position: Q2 2019 in Review

Northwest Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2019, closing a stake of 100 shares — an estimated $2K sold.

Northwest Wealth Management first reported a position in TEVA in Q1 2018 and held it in 5 quarters. The position peaked at $2K in Q1 2019. 452 funds tracked by Wall St. Rank hold TEVA as of Q2 2019.

Northwest Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2019 after selling out during the quarter.
Northwest Wealth Management sold 100 Teva Pharmaceutical Industries Limited shares in Q2 2019, an estimated $2K.
Northwest Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2018 and held it in 5 quarters.
Northwest Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $2K in Q1 2019.
452 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2019.

Based on Northwest Wealth Management's 13F filing for Q2 2019, filed 23 Jul 2019.